Nicorette Mentholmint (Nicotine Resinate 20%)

Nicotine, the active ingredient in Nicorette Mentholmint, is a nicotine replacement therapy presented as a 20% nicotine resinate oromucosal mint for oromucosal use. The mint dissolves slowly in the mouth, delivering nicotine through the oral mucosa to assist adult smokers in reducing withdrawal symptoms and cravings during quit attempts.

GNH USA supplies Nicorette Mentholmint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals, and clinics worldwide, adhering to EU quality standards and providing reliable sourcing for nicotine replacement therapy products.

Nicotine Resinate, a nicotine replacement therapy, is used to support smoking cessation by addressing nicotine dependence. - Smoking cessation: helps adult smokers quit by reducing cravings and withdrawal symptoms. - Nicotine dependence management: provides a controlled nicotine dose to ease transition away from cigarettes. - Gradual reduction of cigarette consumption: allows users to taper nicotine intake while decreasing the number of smoked cigarettes.

Nicotine Resinate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat irritation: discomfort or scratchy feeling in the throat. - Nausea: feeling of queasiness or upset stomach. - Headache: mild to moderate head pain. - Dizziness: transient light‑headedness. - Hiccups: involuntary diaphragm contractions.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Chest pain: unexpected discomfort in the chest area. - Irregular heartbeat: palpitations or arrhythmia. - Severe nausea or vomiting: persistent and intense gastrointestinal upset. - Oral ulceration: painful sores in the mouth. - Increased blood pressure: notable rise in systolic or diastolic pressure.

When using Nicotine Resinate, several precautions should be observed to ensure safe and effective therapy. - Assess nicotine dependence: evaluate the level of dependence before initiating therapy. - Not for non‑smokers: avoid use in individuals who do not regularly smoke tobacco. - Cardiovascular risk: avoid or use with caution in patients with recent myocardial infarction or unstable angina. - Hypertension caution: monitor blood pressure in patients with known hypertension. - Pregnancy and breastfeeding: use only if clearly needed and after professional advice. - Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Nicotine Resinate can interact with other medicines, affecting its safety or efficacy.

Major Interactions (Avoid): - Concurrent nicotine replacement products: using multiple NRTs can cause nicotine overdose. - Nicotine‑containing e‑cigarettes or tobacco: simultaneous use increases nicotine exposure. - Monoamine oxidase inhibitors (MAOIs): may enhance nicotine’s cardiovascular effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine may blunt the heart‑rate‑lowering effect. - Antihypertensive agents: nicotine can raise blood pressure, requiring dose adjustment. - Insulin or oral hypoglycemics: nicotine may affect glucose control, necessitating monitoring.